Octopai’s best-in-class data lineage and catalog platform to provide discoverability, quality, and governance for enterprises to enhance data-driven decision making SANTA CLARA, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Cloudera, the only true hybrid platform for data, analytics, and AI, announced that it entered into a definitive agreement with Octopai B.I.

Octopai’s best-in-class data lineage and catalog platform to provide discoverability, quality, and governance for enterprises to enhance data-driven decision making SANTA CLARA, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Cloudera, the only true hybrid platform for data, analytics, and AI, announced that it entered into a definitive agreement with Octopai B.I.

Octopai’s best-in-class data lineage and catalog platform to provide discoverability, quality, and governance for enterprises to enhance data-driven decision making SANTA CLARA, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) — Cloudera, the only true hybrid platform for data, analytics, and AI, announced that it entered into a definitive agreement with Octopai B.I.

VARSOVIE, Pologne, 13 nov. 2024 (GLOBE NEWSWIRE) — Duck Creek Technologies, le fournisseur mondial de solutions intelligentes qui dessine les futurs contours du secteur de l’assurance générale et IARD (incendies, accidents et risques divers), a annoncé l’ouverture de son deuxième centre d’excellence (CoE) à Varsovie, en Pologne. Ce nouveau centre

VARSOVIE, Pologne, 13 nov. 2024 (GLOBE NEWSWIRE) — Duck Creek Technologies, le fournisseur mondial de solutions intelligentes qui dessine les futurs contours du secteur de l’assurance générale et IARD (incendies, accidents et risques divers), a annoncé l’ouverture de son deuxième centre d’excellence (CoE) à Varsovie, en Pologne. Ce nouveau centre

Propelling the Next Phase of Innovation in Chronic Wound Management DEBx Medical is poised for accelerated growth in chronic wound solutions, bolstered by the second round of investment by TVM Capital Healthcare. AMSTERDAM and DUBAI, United Arab Emirates, Nov. 13, 2024 (GLOBE NEWSWIRE) — DEBx Medical, an Amsterdam-based pioneering innovator